Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

15.46
Delayed Data
As of Dec 09
 +0.02 / +0.13%
Today’s Change
13.77
Today|||52-Week Range
119.87
-84.79%
Year-to-Date
Bill Ackman Comments on Valeant Pharmaceuticals International
Dec 09 / GuruFocus News - Paid Partner Content
Why Valeant Pharmaceuticals (VRX) Could Be Positioned for a Slump
Dec 07 / Zacks.com - Paid Partner Content
5 Drug Stocks to Avoid as Trump Vows to Lower Drug Prices
Dec 08 / Zacks.com - Paid Partner Content
Trump warns Wall Street: I'm going to cut drug prices
Dec 07 / CNNMoney.com
Pfizer (PFE) Fined for Price Hike of Anti-Epilepsy Drug in UK
Dec 08 / Zacks.com - Paid Partner Content
24 Questions With Value Investor Jacob Taylor of the UC Davis Graduate School of Mana...
Dec 06 / GuruFocus News - Paid Partner Content
Should Biotech Investors Worry About Donald Trump?
Dec 08 / Zacks.com - Paid Partner Content
Questions Mount at Teva Amid C-suite Change
Dec 06 / TheStreet.com - Paid Partner Content
Cramer: Make a Deal or Face the Wheel
Dec 07 / TheStreet.com - Paid Partner Content
Why Progenics Pharmaceuticals, Inc. Stock Climbed 76.5% in November
Dec 06 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close15.44
Today’s open15.44
Day’s range15.35 - 15.89
Volume9,223,041
Average volume (3 months)22,067,844
Market cap$5.3B
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-131.25%
Earnings growth (this year)-46.13%
Earnings growth (next 5 years)+9.40%
Revenue growth (last year)+26.42%
P/E ratioNM
Price/Sales3.32
Price/Book0.90

Competitors

 Today’s
change
Today’s
% change
IONSIonis Pharmaceutical...-0.99-2.13%
MNKMallinckrodt Plc+0.25+0.48%
UTHRUnited Therapeutics ...-0.18-0.14%
OPKOPKO Health Inc+0.16+1.48%
Data as of 4:02pm ET, 12/09/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)$1.25
Annual revenue (last year)$10.4B
Annual profit (last year)-$291.7M
Net profit margin-2.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive VP-Finance
Paul S. Herendeen
Corporate headquarters
Laval, Quă©bec

Forecasts


Search for Jobs